ATR and small cell lung carcinoma: As shown in Fig. 2E, SCLC cells were significantly (P < 0.0001) more sensitive to ATR inhibition through VE-822, than NSCLC cells (GI50 = 1.9 μMol vs. GI50 = 7.2 μMol, respectively).